# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Morgan Stanley analyst Ronald Kamdem maintains Welltower (NYSE:WELL) with a Overweight and raises the price target from $103...
Welltower® Inc. (NYSE:WELL) ("Welltower" or the "Company") announced today that its operating company, Welltowe...
Keybanc analyst Todd Thomas maintains Welltower (NYSE:WELL) with a Overweight and raises the price target from $95 to $115.
Welltower® Inc. (NYSE:WELL) today announced that it has revised its 2024 outlook. The Company now expects to achieve normalized...